EMIS — Emmis Acquisition Corp.

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $10.31

About Emmis Acquisition Corp.

Emisphere Technologies, Inc. is a commercial stage pharmaceutical and drug delivery company in the United States. The company is headquartered in Roseland, New Jersey.

See the full interactive analysis & chart →

Informational only — not investment advice.